• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Personalized Medicine Market, Global Outlook and Forecast 2025-2032

Personalized Medicine Market, Global Outlook and Forecast 2025-2032

  • Category:Life Sciences
  • Published on : 13 March 2025
  • Pages :144
  • Formats:
  • Report Code:24MRES-8035824
Click for best price

Best Price: $2600

Report Overview

Individualized medication, medication "vary from person to person" , give full consideration to each patient's genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking Others drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.

The global Personalized Medicine market size was estimated at USD 259380 million in 2023 and is projected to reach USD 658143.20 million by 2032, exhibiting a CAGR of 10.90% during the forecast period.

North America Personalized Medicine market size was estimated at USD 80806.09 million in 2023, at a CAGR of 9.34% during the forecast period of 2025 through 2032.

This report provides a deep insight into the global Personalized Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Personalized Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Personalized Medicine market in any manner.
Global Personalized Medicine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Agilent Technologies
Amgen
Astellas Pharma
Astrazeneca
Bayer AG
Celgene Corporation
Glaxosmithkline Plc
Illumina
Johnson & Johnson
Laboratory Corporation
Merck
Novartis AG
Roche Holding AG
Siemens AG
Takeda Pharmaceutical Company Limited

Market Segmentation (by Type)
Personalized Medicine Diagnostics
Personalized Medical Care
Personalized Medicine Therapeutics
Personalized Nutrition and Wellness

Market Segmentation (by Application)
Oncology
Central Nervous System (CNS)
Immunology
Respiratory
Others Applications

Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Personalized Medicine Market
• Overview of the regional outlook of the Personalized Medicine Market:

Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Personalized Medicine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Personalized Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Personalized Medicine
1.2 Key Market Segments
1.2.1 Personalized Medicine Segment by Type
1.2.2 Personalized Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Personalized Medicine Market Overview
2.1 Global Market Overview
2.1.1 Global Personalized Medicine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Personalized Medicine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Personalized Medicine Market Competitive Landscape
3.1 Global Personalized Medicine Sales by Manufacturers (2019-2025)
3.2 Global Personalized Medicine Revenue Market Share by Manufacturers (2019-2025)
3.3 Personalized Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Personalized Medicine Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Personalized Medicine Sales Sites, Area Served, Product Type
3.6 Personalized Medicine Market Competitive Situation and Trends
3.6.1 Personalized Medicine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Personalized Medicine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Personalized Medicine Industry Chain Analysis
4.1 Personalized Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Personalized Medicine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Personalized Medicine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Personalized Medicine Sales Market Share by Type (2019-2025)
6.3 Global Personalized Medicine Market Size Market Share by Type (2019-2025)
6.4 Global Personalized Medicine Price by Type (2019-2025)
7 Personalized Medicine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Personalized Medicine Market Sales by Application (2019-2025)
7.3 Global Personalized Medicine Market Size (M USD) by Application (2019-2025)
7.4 Global Personalized Medicine Sales Growth Rate by Application (2019-2025)
8 Personalized Medicine Market Consumption by Region
8.1 Global Personalized Medicine Sales by Region
8.1.1 Global Personalized Medicine Sales by Region
8.1.2 Global Personalized Medicine Sales Market Share by Region
8.2 North America
8.2.1 North America Personalized Medicine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Personalized Medicine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Personalized Medicine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Personalized Medicine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Personalized Medicine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Personalized Medicine Market Production by Region
9.1 Global Production of Personalized Medicine by Region (2019-2025)
9.2 Global Personalized Medicine Revenue Market Share by Region (2019-2025)
9.3 Global Personalized Medicine Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Personalized Medicine Production
9.4.1 North America Personalized Medicine Production Growth Rate (2019-2025)
9.4.2 North America Personalized Medicine Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Personalized Medicine Production
9.5.1 Europe Personalized Medicine Production Growth Rate (2019-2025)
9.5.2 Europe Personalized Medicine Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Personalized Medicine Production (2019-2025)
9.6.1 Japan Personalized Medicine Production Growth Rate (2019-2025)
9.6.2 Japan Personalized Medicine Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Personalized Medicine Production (2019-2025)
9.7.1 China Personalized Medicine Production Growth Rate (2019-2025)
9.7.2 China Personalized Medicine Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Personalized Medicine Basic Information
10.1.2 Abbott Laboratories Personalized Medicine Product Overview
10.1.3 Abbott Laboratories Personalized Medicine Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories Personalized Medicine SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Agilent Technologies
10.2.1 Agilent Technologies Personalized Medicine Basic Information
10.2.2 Agilent Technologies Personalized Medicine Product Overview
10.2.3 Agilent Technologies Personalized Medicine Product Market Performance
10.2.4 Agilent Technologies Business Overview
10.2.5 Agilent Technologies Personalized Medicine SWOT Analysis
10.2.6 Agilent Technologies Recent Developments
10.3 Amgen
10.3.1 Amgen Personalized Medicine Basic Information
10.3.2 Amgen Personalized Medicine Product Overview
10.3.3 Amgen Personalized Medicine Product Market Performance
10.3.4 Amgen Personalized Medicine SWOT Analysis
10.3.5 Amgen Business Overview
10.3.6 Amgen Recent Developments
10.4 Astellas Pharma
10.4.1 Astellas Pharma Personalized Medicine Basic Information
10.4.2 Astellas Pharma Personalized Medicine Product Overview
10.4.3 Astellas Pharma Personalized Medicine Product Market Performance
10.4.4 Astellas Pharma Business Overview
10.4.5 Astellas Pharma Recent Developments
10.5 Astrazeneca
10.5.1 Astrazeneca Personalized Medicine Basic Information
10.5.2 Astrazeneca Personalized Medicine Product Overview
10.5.3 Astrazeneca Personalized Medicine Product Market Performance
10.5.4 Astrazeneca Business Overview
10.5.5 Astrazeneca Recent Developments
10.6 Bayer AG
10.6.1 Bayer AG Personalized Medicine Basic Information
10.6.2 Bayer AG Personalized Medicine Product Overview
10.6.3 Bayer AG Personalized Medicine Product Market Performance
10.6.4 Bayer AG Business Overview
10.6.5 Bayer AG Recent Developments
10.7 Celgene Corporation
10.7.1 Celgene Corporation Personalized Medicine Basic Information
10.7.2 Celgene Corporation Personalized Medicine Product Overview
10.7.3 Celgene Corporation Personalized Medicine Product Market Performance
10.7.4 Celgene Corporation Business Overview
10.7.5 Celgene Corporation Recent Developments
10.8 Glaxosmithkline Plc
10.8.1 Glaxosmithkline Plc Personalized Medicine Basic Information
10.8.2 Glaxosmithkline Plc Personalized Medicine Product Overview
10.8.3 Glaxosmithkline Plc Personalized Medicine Product Market Performance
10.8.4 Glaxosmithkline Plc Business Overview
10.8.5 Glaxosmithkline Plc Recent Developments
10.9 Illumina
10.9.1 Illumina Personalized Medicine Basic Information
10.9.2 Illumina Personalized Medicine Product Overview
10.9.3 Illumina Personalized Medicine Product Market Performance
10.9.4 Illumina Business Overview
10.9.5 Illumina Recent Developments
10.10 Johnson and Johnson
10.10.1 Johnson and Johnson Personalized Medicine Basic Information
10.10.2 Johnson and Johnson Personalized Medicine Product Overview
10.10.3 Johnson and Johnson Personalized Medicine Product Market Performance
10.10.4 Johnson and Johnson Business Overview
10.10.5 Johnson and Johnson Recent Developments
10.11 Laboratory Corporation
10.11.1 Laboratory Corporation Personalized Medicine Basic Information
10.11.2 Laboratory Corporation Personalized Medicine Product Overview
10.11.3 Laboratory Corporation Personalized Medicine Product Market Performance
10.11.4 Laboratory Corporation Business Overview
10.11.5 Laboratory Corporation Recent Developments
10.12 Merck
10.12.1 Merck Personalized Medicine Basic Information
10.12.2 Merck Personalized Medicine Product Overview
10.12.3 Merck Personalized Medicine Product Market Performance
10.12.4 Merck Business Overview
10.12.5 Merck Recent Developments
10.13 Novartis AG
10.13.1 Novartis AG Personalized Medicine Basic Information
10.13.2 Novartis AG Personalized Medicine Product Overview
10.13.3 Novartis AG Personalized Medicine Product Market Performance
10.13.4 Novartis AG Business Overview
10.13.5 Novartis AG Recent Developments
10.14 Roche Holding AG
10.14.1 Roche Holding AG Personalized Medicine Basic Information
10.14.2 Roche Holding AG Personalized Medicine Product Overview
10.14.3 Roche Holding AG Personalized Medicine Product Market Performance
10.14.4 Roche Holding AG Business Overview
10.14.5 Roche Holding AG Recent Developments
10.15 Siemens AG
10.15.1 Siemens AG Personalized Medicine Basic Information
10.15.2 Siemens AG Personalized Medicine Product Overview
10.15.3 Siemens AG Personalized Medicine Product Market Performance
10.15.4 Siemens AG Business Overview
10.15.5 Siemens AG Recent Developments
10.16 Takeda Pharmaceutical Company Limited
10.16.1 Takeda Pharmaceutical Company Limited Personalized Medicine Basic Information
10.16.2 Takeda Pharmaceutical Company Limited Personalized Medicine Product Overview
10.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Product Market Performance
10.16.4 Takeda Pharmaceutical Company Limited Business Overview
10.16.5 Takeda Pharmaceutical Company Limited Recent Developments
11 Personalized Medicine Market Forecast by Region
11.1 Global Personalized Medicine Market Size Forecast
11.2 Global Personalized Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Personalized Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Personalized Medicine Market Size Forecast by Region
11.2.4 South America Personalized Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Personalized Medicine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Personalized Medicine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Personalized Medicine by Type (2025-2032)
12.1.2 Global Personalized Medicine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Personalized Medicine by Type (2025-2032)
12.2 Global Personalized Medicine Market Forecast by Application (2025-2032)
12.2.1 Global Personalized Medicine Sales (K Units) Forecast by Application
12.2.2 Global Personalized Medicine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Personalized Medicine Market Size Comparison by Region (M USD)
Table 5. Global Personalized Medicine Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Personalized Medicine Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Personalized Medicine Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Personalized Medicine Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine as of 2022)
Table 10. Global Market Personalized Medicine Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Personalized Medicine Sales Sites and Area Served
Table 12. Manufacturers Personalized Medicine Product Type
Table 13. Global Personalized Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Personalized Medicine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Personalized Medicine Market Challenges
Table 22. Global Personalized Medicine Sales by Type (K Units)
Table 23. Global Personalized Medicine Market Size by Type (M USD)
Table 24. Global Personalized Medicine Sales (K Units) by Type (2019-2025)
Table 25. Global Personalized Medicine Sales Market Share by Type (2019-2025)
Table 26. Global Personalized Medicine Market Size (M USD) by Type (2019-2025)
Table 27. Global Personalized Medicine Market Size Share by Type (2019-2025)
Table 28. Global Personalized Medicine Price (USD/Unit) by Type (2019-2025)
Table 29. Global Personalized Medicine Sales (K Units) by Application
Table 30. Global Personalized Medicine Market Size by Application
Table 31. Global Personalized Medicine Sales by Application (2019-2025) & (K Units)
Table 32. Global Personalized Medicine Sales Market Share by Application (2019-2025)
Table 33. Global Personalized Medicine Sales by Application (2019-2025) & (M USD)
Table 34. Global Personalized Medicine Market Share by Application (2019-2025)
Table 35. Global Personalized Medicine Sales Growth Rate by Application (2019-2025)
Table 36. Global Personalized Medicine Sales by Region (2019-2025) & (K Units)
Table 37. Global Personalized Medicine Sales Market Share by Region (2019-2025)
Table 38. North America Personalized Medicine Sales by Country (2019-2025) & (K Units)
Table 39. Europe Personalized Medicine Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Personalized Medicine Sales by Region (2019-2025) & (K Units)
Table 41. South America Personalized Medicine Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Personalized Medicine Sales by Region (2019-2025) & (K Units)
Table 43. Global Personalized Medicine Production (K Units) by Region (2019-2025)
Table 44. Global Personalized Medicine Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Personalized Medicine Revenue Market Share by Region (2019-2025)
Table 46. Global Personalized Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Personalized Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Personalized Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Personalized Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Personalized Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Abbott Laboratories Personalized Medicine Basic Information
Table 52. Abbott Laboratories Personalized Medicine Product Overview
Table 53. Abbott Laboratories Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Abbott Laboratories Business Overview
Table 55. Abbott Laboratories Personalized Medicine SWOT Analysis
Table 56. Abbott Laboratories Recent Developments
Table 57. Agilent Technologies Personalized Medicine Basic Information
Table 58. Agilent Technologies Personalized Medicine Product Overview
Table 59. Agilent Technologies Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Agilent Technologies Business Overview
Table 61. Agilent Technologies Personalized Medicine SWOT Analysis
Table 62. Agilent Technologies Recent Developments
Table 63. Amgen Personalized Medicine Basic Information
Table 64. Amgen Personalized Medicine Product Overview
Table 65. Amgen Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Amgen Personalized Medicine SWOT Analysis
Table 67. Amgen Business Overview
Table 68. Amgen Recent Developments
Table 69. Astellas Pharma Personalized Medicine Basic Information
Table 70. Astellas Pharma Personalized Medicine Product Overview
Table 71. Astellas Pharma Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Astellas Pharma Business Overview
Table 73. Astellas Pharma Recent Developments
Table 74. Astrazeneca Personalized Medicine Basic Information
Table 75. Astrazeneca Personalized Medicine Product Overview
Table 76. Astrazeneca Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Astrazeneca Business Overview
Table 78. Astrazeneca Recent Developments
Table 79. Bayer AG Personalized Medicine Basic Information
Table 80. Bayer AG Personalized Medicine Product Overview
Table 81. Bayer AG Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Recent Developments
Table 84. Celgene Corporation Personalized Medicine Basic Information
Table 85. Celgene Corporation Personalized Medicine Product Overview
Table 86. Celgene Corporation Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Celgene Corporation Business Overview
Table 88. Celgene Corporation Recent Developments
Table 89. Glaxosmithkline Plc Personalized Medicine Basic Information
Table 90. Glaxosmithkline Plc Personalized Medicine Product Overview
Table 91. Glaxosmithkline Plc Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Glaxosmithkline Plc Business Overview
Table 93. Glaxosmithkline Plc Recent Developments
Table 94. Illumina Personalized Medicine Basic Information
Table 95. Illumina Personalized Medicine Product Overview
Table 96. Illumina Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Illumina Business Overview
Table 98. Illumina Recent Developments
Table 99. Johnson and Johnson Personalized Medicine Basic Information
Table 100. Johnson and Johnson Personalized Medicine Product Overview
Table 101. Johnson and Johnson Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Johnson and Johnson Business Overview
Table 103. Johnson and Johnson Recent Developments
Table 104. Laboratory Corporation Personalized Medicine Basic Information
Table 105. Laboratory Corporation Personalized Medicine Product Overview
Table 106. Laboratory Corporation Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Laboratory Corporation Business Overview
Table 108. Laboratory Corporation Recent Developments
Table 109. Merck Personalized Medicine Basic Information
Table 110. Merck Personalized Medicine Product Overview
Table 111. Merck Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Merck Business Overview
Table 113. Merck Recent Developments
Table 114. Novartis AG Personalized Medicine Basic Information
Table 115. Novartis AG Personalized Medicine Product Overview
Table 116. Novartis AG Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Novartis AG Business Overview
Table 118. Novartis AG Recent Developments
Table 119. Roche Holding AG Personalized Medicine Basic Information
Table 120. Roche Holding AG Personalized Medicine Product Overview
Table 121. Roche Holding AG Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. Roche Holding AG Business Overview
Table 123. Roche Holding AG Recent Developments
Table 124. Siemens AG Personalized Medicine Basic Information
Table 125. Siemens AG Personalized Medicine Product Overview
Table 126. Siemens AG Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 127. Siemens AG Business Overview
Table 128. Siemens AG Recent Developments
Table 129. Takeda Pharmaceutical Company Limited Personalized Medicine Basic Information
Table 130. Takeda Pharmaceutical Company Limited Personalized Medicine Product Overview
Table 131. Takeda Pharmaceutical Company Limited Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 132. Takeda Pharmaceutical Company Limited Business Overview
Table 133. Takeda Pharmaceutical Company Limited Recent Developments
Table 134. Global Personalized Medicine Sales Forecast by Region (2025-2032) & (K Units)
Table 135. Global Personalized Medicine Market Size Forecast by Region (2025-2032) & (M USD)
Table 136. North America Personalized Medicine Sales Forecast by Country (2025-2032) & (K Units)
Table 137. North America Personalized Medicine Market Size Forecast by Country (2025-2032) & (M USD)
Table 138. Europe Personalized Medicine Sales Forecast by Country (2025-2032) & (K Units)
Table 139. Europe Personalized Medicine Market Size Forecast by Country (2025-2032) & (M USD)
Table 140. Asia Pacific Personalized Medicine Sales Forecast by Region (2025-2032) & (K Units)
Table 141. Asia Pacific Personalized Medicine Market Size Forecast by Region (2025-2032) & (M USD)
Table 142. South America Personalized Medicine Sales Forecast by Country (2025-2032) & (K Units)
Table 143. South America Personalized Medicine Market Size Forecast by Country (2025-2032) & (M USD)
Table 144. Middle East and Africa Personalized Medicine Consumption Forecast by Country (2025-2032) & (Units)
Table 145. Middle East and Africa Personalized Medicine Market Size Forecast by Country (2025-2032) & (M USD)
Table 146. Global Personalized Medicine Sales Forecast by Type (2025-2032) & (K Units)
Table 147. Global Personalized Medicine Market Size Forecast by Type (2025-2032) & (M USD)
Table 148. Global Personalized Medicine Price Forecast by Type (2025-2032) & (USD/Unit)
Table 149. Global Personalized Medicine Sales (K Units) Forecast by Application (2025-2032)
Table 150. Global Personalized Medicine Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Personalized Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Personalized Medicine Market Size (M USD), 2019-2032
Figure 5. Global Personalized Medicine Market Size (M USD) (2019-2032)
Figure 6. Global Personalized Medicine Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Personalized Medicine Market Size by Country (M USD)
Figure 11. Personalized Medicine Sales Share by Manufacturers in 2023
Figure 12. Global Personalized Medicine Revenue Share by Manufacturers in 2023
Figure 13. Personalized Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Personalized Medicine Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Personalized Medicine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Personalized Medicine Market Share by Type
Figure 18. Sales Market Share of Personalized Medicine by Type (2019-2025)
Figure 19. Sales Market Share of Personalized Medicine by Type in 2023
Figure 20. Market Size Share of Personalized Medicine by Type (2019-2025)
Figure 21. Market Size Market Share of Personalized Medicine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Personalized Medicine Market Share by Application
Figure 24. Global Personalized Medicine Sales Market Share by Application (2019-2025)
Figure 25. Global Personalized Medicine Sales Market Share by Application in 2023
Figure 26. Global Personalized Medicine Market Share by Application (2019-2025)
Figure 27. Global Personalized Medicine Market Share by Application in 2023
Figure 28. Global Personalized Medicine Sales Growth Rate by Application (2019-2025)
Figure 29. Global Personalized Medicine Sales Market Share by Region (2019-2025)
Figure 30. North America Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Personalized Medicine Sales Market Share by Country in 2023
Figure 32. U.S. Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Personalized Medicine Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Personalized Medicine Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Personalized Medicine Sales Market Share by Country in 2023
Figure 37. Germany Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Personalized Medicine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Personalized Medicine Sales Market Share by Region in 2023
Figure 44. China Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Personalized Medicine Sales and Growth Rate (K Units)
Figure 50. South America Personalized Medicine Sales Market Share by Country in 2023
Figure 51. Brazil Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Personalized Medicine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Personalized Medicine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Personalized Medicine Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Personalized Medicine Production Market Share by Region (2019-2025)
Figure 62. North America Personalized Medicine Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Personalized Medicine Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Personalized Medicine Production (K Units) Growth Rate (2019-2025)
Figure 65. China Personalized Medicine Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Personalized Medicine Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Personalized Medicine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Personalized Medicine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Personalized Medicine Market Share Forecast by Type (2025-2032)
Figure 70. Global Personalized Medicine Sales Forecast by Application (2025-2032)
Figure 71. Global Personalized Medicine Market Share Forecast by Application (2025-2032)

SELECT A FORMAT

USD GBP EURO YEN Single User License
USD GBP EURO YEN Multi User License
USD GBP EURO YEN Corporate User License

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount